Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FOLH1 | Q04609 | 4/20 | 0.62 |
| ▸ | DPP4 | P27487 | 1/20 | 0.53 |
| ▸ | DPP8 | Q6V1X1 | 1/20 | 0.53 |
| ▸ | DPP9 | Q86TI2 | 1/20 | 0.53 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.52 |
| ▸ | GSTK1 | Q9Y2Q3 | 1/20 | 0.52 |
| ▸ | GRM8 | O00222 | 1/20 | 0.52 |
| ▸ | GRM6 | O15303 | 1/20 | 0.52 |
| ▸ | GRIN2D | O15399 | 1/20 | 0.52 |
| ▸ | GRIN3B | O60391 | 1/20 | 0.52 |
| ▸ | GSR | P00390 | 1/20 | 0.52 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.52 |
| ▸ | GRIK1 | P39086 | 1/20 | 0.52 |
| ▸ | GRM5 | P41594 | 1/20 | 0.52 |
| ▸ | GRIA1 | P42261 | 1/20 | 0.52 |
| ▸ | GRIA2 | P42262 | 1/20 | 0.52 |
| ▸ | GRIA3 | P42263 | 1/20 | 0.52 |
| ▸ | SLC1A3 | P43003 | 1/20 | 0.52 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.52 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL536354 | 1.00 | FOLH1 (0.62) | FOLH1DPP4DPP8DPP9PTGS1 | |
| SCHEMBL15420942 | 1.00 | FOLH1 (0.62) | FOLH1DPP4DPP8DPP9PTGS1 | |
| SCHEMBL210006 | 1.00 | FOLH1 (0.62) | FOLH1DPP4DPP8DPP9PTGS1 | |
| SCHEMBL15420941 | 1.00 | FOLH1 (0.62) | FOLH1DPP4DPP8DPP9PTGS1 | |
| SCHEMBL27611010 | 0.97 | FOLH1 (0.58) | FOLH1DPP4DPP8DPP9PTGS1 | |
| SCHEMBL27611015 | 0.97 | FOLH1 (0.58) | FOLH1DPP4DPP8DPP9PTGS1 | |
| SCHEMBL16770243 | 0.97 | FOLH1 (0.58) | FOLH1DPP4DPP8DPP9PTGS1 | |
| Glycine SCHEMBL343653 | 0.95 | FOLH1 (0.57) | FOLH1DPP4DPP8DPP9PTGS1 | |
| SCHEMBL9760353 | 0.95 | FOLH1 (0.61) | FOLH1DPP4DPP8DPP9PTGS1 | |
| SCHEMBL30382437 | 0.95 | FOLH1 (0.61) | FOLH1DPP4DPP8DPP9PTGS1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 32 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1406592-A2 | A SALT/ION PAIR MEDICINAL AEROSOL FORMULATION | Aeropharm Technology Incorporated (US) | 2004-04-14 | — | — | EP | claimed |
| WO-2003007867-A2 | A SALT/ION PAIR MEDICINAL AEROSOL FORMULATION | AEROPHRAM TECHNOLOGY, INC. (US) | 2003-01-30 | — | — | WO | claimed |
| EP-0604433-A4 | COMPOSITION AND METHOD FOR DISEASE TREATMENT. | LIFE SCIENCES TECH INC (US) | 1994-10-12 | — | — | EP | claimed |
| EP-0604433-A1 | COMPOSITION AND METHOD FOR DISEASE TREATMENT | LIFE SCIENCES' TECHNOLOGIES, INC. (US) | 1994-07-06 | — | — | EP | claimed |
| WO-1992021368-A1 | COMPOSITION AND METHOD FOR DISEASE TREATMENT | LIFE SCIENCES' TECHNOLOGIES, INC. (US) | 1992-12-10 | — | — | WO | claimed |
| EP-4551203-A1 | OPHTHALMIC IMPLANT | NaCuity Pharmaceuticals, Inc. (US) | 2025-05-14 | — | — | EP | disclosed |
| CN-119894506-A | Ophthalmic implant | 纳崔泰制药有限公司 | 2025-04-25 | — | — | CN | disclosed |
| WO-2024061920-A1 | METHOD FOR ASSESSING THE ACTIVITY OF NICOTINAMIDE N-METHYLTRANSFERASE | FUNDACIÓN PARA LA INVESTIGACIÓN DEL HOSPITAL UNIVERSITARIO Y POLITÉCNICO DE LA FE DE LA COMUNIDAD VALENCIANA (ES) | 2024-03-28 | — | — | WO | disclosed |
| EP-4339296-A1 | METHOD FOR ASSESSING THE ACTIVITY OF NICOTINAMIDE N-METHYLTRANSFERASE | Fundación para la Investigación Hospital Universitario y Politécnico La Fe de la Comunidad Valenciana (ES) | 2024-03-20 | — | — | EP | disclosed |
| WO-2024011230-A1 | OPHTHALMIC IMPLANT | NACUITY PHARMACEUTICALS, INC. (US) | 2024-01-11 | — | — | WO | disclosed |
| CN-117187199-A | Glutathione synthetase with enhanced activity and application | 南京朗恩生物科技有限公司 | 2023-12-08 | — | — | CN | disclosed |
| CN-116926024-A | Glutathione synthetase with enhanced heat resistance and application | 南京朗恩生物科技有限公司 | 2023-10-24 | — | — | CN | disclosed |
| US-20090155440-A1 | Salt Enhancing Compounds and Use | GIVAUDAN SA (CH) | 2009-06-18 | — | — | US | disclosed |
| US-20090130282-A1 | Kokumi Flavour Compounds and Use | GIVAUDAN SA (CH) | 2009-05-21 | — | — | US | disclosed |
| WO-2009052186-A1 | METABOLOMICS-BASED IDENTIFICATION OF DISEASE-CAUSING AGENTS | GEORGIA TECH RESEARCH CORPORATION (US) | 2009-04-23 | — | — | WO | disclosed |
| EP-1968650-A2 | COMPOUNDS FOR DELIVERING AMINO ACIDS OR PEPTIDES WITH ANTIOXIDANT ACTIVITY INTO MITOCHONDRIA AND USE THEREOF | University of Rochester (US) | 2008-09-17 | — | — | EP | disclosed |
| US-20070298484-A1 | Method and Device for Thermal Conditioning of a Cell | INSILICO BIOTECHNOLOGY GMBH (DE) | 2007-12-27 | — | — | US | disclosed |
| WO-2007076323-A2 | COMPOUNDS FOR DELIVERING AMINO ACIDS OR PEPTIDES WITH ANTIOXIDANT ACTIVITY INTO MITOCHONDRIA AND USE THEREOF | UNIVERSITY OF ROCHESTER (US) | 2007-07-05 | — | — | WO | disclosed |
| WO-2006063116-A2 | BIFUNCTIONAL ENZYME WITH Ϝ-GLUTAMYLEYSTEINE SYNTHETASE AND GLUTATHIONE SYNTHETASE ACTIVITY AND USES THEREOF | GRIFFITH OWEN W (US) | 2006-06-15 | — | — | WO | disclosed |
| EP-0315949-A2 | A method for microbiological reaction | IDEMITSU KOSAN COMPANY LIMITED (JP) | 1989-05-17 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090130282-A1 | Kokumi Flavour Compounds and Use | KHK, KLK5, KCNK5 | FOLH1 777/4885DPP4 1517/4885DPP8 1034/4885 |
| US-20090155440-A1 | Salt Enhancing Compounds and Use | TAS1R1, TAS2R41, TAS2R40 | FOLH1 651/4885DPP4 825/4885DPP8 839/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.